A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Titel:
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Auteur:
Penel, Nicolas Mir, Olivier Wallet, Jennifer Ray-Coquard, Isabelle Le Cesne, Axel Italiano, Antoine Salas, Sebastien Delcambre, Corinne Bompas, Emmanuelle Bertucci, François Saada-Bouzid, Esma Chaigneau, Loïc Chevreau, Christine Brodowicz, Thomas Decoupigny, Emilie Vanseymortier, Marie Laroche, Lucie Taieb, Sophie Le Deley, Marie-Cécile Blay, Jean-Yves